Corporate & Investor Presentation
Who we are / what we do
•
●
.
Listed on NYSE & ASX, ~$30B market cap
World-leading digital health company with over 13.5 million
100% cloud-connectable devices
- 15+ million patients in AirView monitoring ecosystem.
-
100+ million patient accounts in out-of-hospital care network
Innovative designer and manufacturer of award-winning devices and
cloud-based software solutions
85
T60 pelus
- Diagnose, treat, and manage sleep apnea, chronic obstructive pulmonary disease,
and other respiratory conditions
Excellens results, Alented
Products and solutions designed to improve patient quality of life, reduce
impact of chronic disease, and lower healthcare costs
•
Cloud-based software solutions and devices designed to provide connected care,
improving patient outcomes and efficiencies for healthcare providers
-
Tools that allow fewer people to manage more patients
- Empower patients to track own health outcomes
4 2021 ResMed | Corporate & Investor Presentation - updated 28JAN21
ResMed
舍
ResMedView entire presentation